chr9-137307640-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017820.5(EXD3):āc.2285A>Gā(p.Glu762Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000185 in 1,457,496 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_017820.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EXD3 | NM_017820.5 | c.2285A>G | p.Glu762Gly | missense_variant | 21/22 | ENST00000340951.9 | NP_060290.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EXD3 | ENST00000340951.9 | c.2285A>G | p.Glu762Gly | missense_variant | 21/22 | 1 | NM_017820.5 | ENSP00000340474.4 | ||
EXD3 | ENST00000491734.6 | n.*1386-377A>G | intron_variant | 1 | ENSP00000435830.1 | |||||
EXD3 | ENST00000487745.5 | n.1613A>G | non_coding_transcript_exon_variant | 11/12 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000409 AC: 1AN: 244560Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 133554
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1457496Hom.: 0 Cov.: 32 AF XY: 0.0000221 AC XY: 16AN XY: 725204
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 02, 2024 | The c.2285A>G (p.E762G) alteration is located in exon 21 (coding exon 20) of the EXD3 gene. This alteration results from a A to G substitution at nucleotide position 2285, causing the glutamic acid (E) at amino acid position 762 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at